Levodopa/benserazide

(Redirected from Madopar)

Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.[2][3][4]

Levodopa/benserazide
Combination of
LevodopaDopamine agonist
BenserazideDecarboxylase inhibitors
Clinical data
Trade namesProlopa, Madopar, others[1]
Pregnancy
category
Routes of
administration
By mouth
ATC code
Legal status
Legal status
Identifiers
KEGG

Medical uses

edit

Levodopa/benserazide is indicated for the treatment of Parkinson's disease with the exception of drug-induced parkinsonism.[2][3][4]

References

edit
  1. ^ "Levodopa".
  2. ^ a b c d "Madopar Product Information". Medsinfo. 8 July 2019. Retrieved 2 September 2024.
  3. ^ a b c "Prolopa Product information". Health Canada. 25 April 2012. Retrieved 8 January 2023.
  4. ^ a b c "Madopar 100 mg/25 mg Dispersible Tablets - Summary of Product Characteristics (SmPC)". (emc). 8 April 2020. Retrieved 9 January 2023.
edit